FGP
Foyston, Gordon, & Payne’s Novo Nordisk NVO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,368
| Closed | -$937K | – | 65 |
|
|
2021
Q4 | $937K | Hold |
8,368
| – | – | 0.22% | 53 |
|
|
2021
Q3 | $803K | Hold |
8,368
| – | – | 0.2% | 52 |
|
|
2021
Q2 | $701K | Sell |
8,368
-14,448
| -63% | -$1.21M | 0.17% | 61 |
|
|
2021
Q1 | $1.54M | Sell |
22,816
-6
| -0% | -$404 | 0.36% | 53 |
|
|
2020
Q4 | $1.59M | Sell |
22,822
-26
| -0.1% | -$1.82K | 0.38% | 52 |
|
|
2020
Q3 | $1.59M | Sell |
22,848
-60
| -0.3% | -$4.17K | 0.41% | 52 |
|
|
2020
Q2 | $1.5M | Sell |
22,908
-79
| -0.3% | -$5.17K | 0.37% | 51 |
|
|
2020
Q1 | $1.38M | Buy |
22,987
+55
| +0.2% | +$3.31K | 0.36% | 48 |
|
|
2019
Q4 | $1.33M | Sell |
22,932
-35,945
| -61% | -$2.08M | 0.25% | 49 |
|
|
2019
Q3 | $3.04M | Sell |
58,877
-1,519
| -3% | -$78.5K | 0.61% | 36 |
|
|
2019
Q2 | $3.08M | Sell |
60,396
-987
| -2% | -$50.4K | 0.58% | 34 |
|
|
2019
Q1 | $3.21M | Sell |
61,383
-207
| -0.3% | -$10.8K | 0.61% | 31 |
|
|
2018
Q4 | $2.84M | Sell |
61,590
-588
| -0.9% | -$27.1K | 0.57% | 35 |
|
|
2018
Q3 | $2.93M | Buy |
62,178
+634
| +1% | +$29.9K | 0.5% | 37 |
|
|
2018
Q2 | $2.84M | Sell |
61,544
-45,004
| -42% | -$2.08M | 0.52% | 41 |
|
|
2018
Q1 | $5.25M | Sell |
106,548
-2,944
| -3% | -$145K | 1.01% | 28 |
|
|
2017
Q4 | $5.88M | Sell |
109,492
-61,980
| -36% | -$3.33M | 1.12% | 28 |
|
|
2017
Q3 | $8.26M | Buy |
171,472
+56,941
| +50% | +$2.74M | 1.43% | 23 |
|
|
2017
Q2 | $4.91M | Sell |
114,531
-2,861
| -2% | -$123K | 1.06% | 29 |
|
|
2017
Q1 | $4.02M | Buy |
117,392
+23,335
| +25% | +$800K | 0.87% | 34 |
|
|
2016
Q4 | $3.37M | Buy |
+94,057
| New | +$3.37M | 0.8% | 42 |
|